Two Sigma Securities
INM icon

Two Sigma Securities’s InMed Pharmaceuticals INM Stock Holding History

Two Sigma Securities’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Sell
1,095
-777
-42% -$8.58K ﹤0.01% 1507
2026
Q1 		$12.1K Buy
+1,872
New +$17.6K ﹤0.01% 1447
2024
Q2 		– Sell
-77
Closed -$5.61K – 3314
2024
Q1 		$5.61K Buy
77
+13
+20% +$956 ﹤0.01% 2826
2023
Q4 		$5.36K Buy
+64
New +$6.21K ﹤0.01% 2876
2022
Q2 		– Sell
-4
Closed -$17K – 2520
2022
Q1 		$17K Buy
+4
New +$21K ﹤0.01% 1996

Other funds holding INM

ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Squadron Capital Management
Squadron Capital Management Westmont, Illinois $322M AUM
Ikarian Capital
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Ursa Fund Management
Ursa Fund Management Danville, California $1.28B AUM 89.11% 1-Year Est. Return
Suvretta Capital Management
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Two Sigma Securities's INM Position: Q2 2026 in Review

Two Sigma Securities reduced its InMed Pharmaceuticals (INM) stake by 42% in Q2 2026, selling an estimated $8.58K and leaving 1,095 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1507.

Two Sigma Securities first reported a position in INM in Q1 2022 and has held it in 5 quarters since. The position peaked at $17K in Q1 2022. 19 funds tracked by Wall St. Rank hold INM as of Q2 2026.

  • Two Sigma Securities held 1,095 shares of InMed Pharmaceuticals worth $17K as of Q2 2026.
  • Two Sigma Securities sold 777 InMed Pharmaceuticals shares in Q2 2026, an estimated $8.58K.
  • InMed Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1507 holding.
  • Two Sigma Securities first reported a position in InMed Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
  • Two Sigma Securities's InMed Pharmaceuticals position peaked at $17K in Q1 2022.
  • 19 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.